Rimactazid Paed 60/60 is a medication used in the treatment of tuberculosis (TB) in pediatric patients. It contains two active ingredients: rifampicin and isoniazid. Rifampicin is an antibiotic that kills or inhibits the growth of the bacteria causing tuberculosis, while isoniazid is an antimicrobial agent that works alongside rifampicin to treat the infection.
Dosage and Administration:
The dosage of Rimactazid Paed 60/60 depends on the weight of the child and should be determined by a healthcare professional. The medication is typically given as a combination of rifampicin and isoniazid in a fixed ratio of 60 mg of rifampicin and 60 mg of isoniazid per tablet.
The recommended dosage for Rimactazid Paed 60/60 in pediatric patients is generally based on the weight of the child. It is usually administered once daily, preferably on an empty stomach, at least one hour before or two hours after a meal.
The duration of treatment with Rimactazid Paed 60/60 for tuberculosis varies depending on the severity of the infection and the specific treatment regimen prescribed by the doctor. It is crucial to complete the full course of treatment as directed by the healthcare professional, even if the symptoms improve or disappear before the treatment is finished.
Usage Information:
Rimactazid Paed 60/60 tablets should be swallowed whole with water. It is not recommended to crush or chew the tablets. If a child has difficulty swallowing the tablet, it can be crushed and mixed with a small amount of food or liquid, such as water, immediately before administration. It is important to consume the entire mixture to ensure the full dose is taken.
Precautions and Side Effects:
Prior to starting treatment with Rimactazid Paed 60/60, it is essential to inform the doctor about any known allergies or sensitivities to rifampicin, isoniazid, or any other medications. Additionally, disclose any underlying medical conditions or ongoing treatments to avoid potential interactions.
While Rimactazid Paed 60/60 is generally well-tolerated, it may cause side effects in some individuals. Common side effects include gastrointestinal disturbances (such as nausea, vomiting, or abdominal discomfort), skin rashes, and liver function abnormalities. If any severe side effects or allergic reactions occur, it is important to seek immediate medical attention.
It is crucial to strictly adhere to the prescribed dosage and treatment regimen for Rimactazid Paed 60/60 to ensure effective treatment of tuberculosis. Regular monitoring by a healthcare professional is typically necessary to evaluate the child’s response to treatment and to monitor for any potential side effects or complications.
Please note that the information provided here is a general overview of Rimactazid Paed 60/60. Always consult a healthcare professional or your child’s doctor for personalized dosage and usage instructions based on the specific condition and medical history of the child.